TLX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Telix Pharmaceuticals Ltd

Watchlist Manager

Watchlist

Price: 16.01 AUD -0.5% Market Closed

Market Cap: AU$5.4B

	Telix Pharmaceuticals Ltd ASX:TLX	AU
S	Stora Enso Oyj DUS:ENUR	FI
N	Nexon Co Ltd TSE:3659	JP
V	Vertex Pharmaceuticals Inc F:VX1	US
T	Tsingtao Brewery Co Ltd XMUN:TSI	CN
S	Swiss Re AG F:SR9	CH

Profitability Summary

Telix Pharmaceuticals Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

48%

Strong 3Y Average Gross Margin

56%

Declining Gross Margin

62% > 48%

Low Operating Margin

Low 3Y Average Operating Margin

Operating Margin is Increasing

-7% > 7%

Low Net Margin

Low 3Y Average Net Margin

Net Margin is Increasing

-13% > 4%

Negative Free Cash Flow Margin

-7%

Negative 3Y Average Free Cash Flow Margin

-3%

Declining Free Cash Flow Margin

Positive 3Y Average ROIC

13%

ROIC is Increasing

-28% > 8%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.